Vattulainen, Meri
Ilmarinen, Tanja
Koivusalo, Laura
Viiri, Keijo
Hongisto, Heidi
Skottman, Heli
Funding for this research was provided by:
Academy of Finland (297886, 310011)
Sigrid Juséliuksen Säätiö
Business Finland
Suomen Kulttuurirahasto
Silmä- ja kudospankkisäätiö
Article History
Received: 25 June 2019
Revised: 19 July 2019
Accepted: 22 July 2019
First Online: 5 August 2019
Ethics approval and consent to participate
: The laboratory has the approval of the National Authority for Medicolegal Affairs in Finland and supportive statement of the Ethics Committee of Pirkanmaa Hospital District in Finland, considering the use of human embryos and human pluripotent stem cells for ophthalmic research purposes. No new hPSC lines were generated for this study. The porcine corneas used in this study were acquired from the local abattoir as a side product and were thus not the sole reason for animal sacrifice.
: Not applicable.
: Tampere University Finland has a patent pending regarding the novel hPSC-LSC maintenance method fully reported herein. Based on the Act on the Right in Inventions made at Higher Education Institutions in Finland, all authors employed by Tampere University have given all rights to the University and thus the authors declare that they have no competing interests.